Literature DB >> 11767065

A serodiagnostic ELISA using recombinant antigen of swine transmissible gastroenteritis virus nucleoprotein.

C Liu1, T Kokuho, T Kubota, S Watanabe, S Inumaru, Y Yokomizo, T Onodera.   

Abstract

A serodiagnostic ELISA utilizing the recombinant nucleoprotein (rN protein) of transmissible gastroenteritis virus (TGEV) was developed, and evaluated by examining a panel of 141 virus neutralization (VN) positive and 101 negative sera. The rN protein-based ELISA (rnELISA) appeared to be highly sensitive and specific (98.6% and 98.0%, respectively) when it was compared to the VN test. The result was similar to that of an ELISA based on purified viral antigens with showing good correlation (R=0.829). No cross-reaction was detected with antisera against porcine epidemic diarrhea virus, hog cholera virus, type A rotavirus, pseudorabies virus and swine vesicular disease virus in this ELISA. The rnELISA can be an alternative for the diagnosis of TGE with a great advantage in antigen preparation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767065     DOI: 10.1292/jvms.63.1253

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

1.  Phage display for identifying peptides that bind the spike protein of transmissible gastroenteritis virus and possess diagnostic potential.

Authors:  Siqingaowa Suo; Xue Wang; Dante Zarlenga; Ri-E Bu; Yudong Ren; Xiaofeng Ren
Journal:  Virus Genes       Date:  2015-05-27       Impact factor: 2.332

2.  Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43.

Authors:  Thomas Mourez; Astrid Vabret; Yang Han; Julia Dina; Loïc Legrand; Sandrine Corbet; François Freymuth
Journal:  J Virol Methods       Date:  2006-10-31       Impact factor: 2.014

3.  Development of a novel real-time RT-PCR assay with LUX primer for the detection of swine transmissible gastroenteritis virus.

Authors:  Ru Chen; Weiming Huang; Zhixiong Lin; Zhongfang Zhou; Haiqiong Yu; Daozhong Zhu
Journal:  J Virol Methods       Date:  2004-12-01       Impact factor: 2.014

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.